HARTE-HANKS, Inc. (NY:HHS)
10.15
+0.03 (0.30%)
| HARTE-HANKS, Inc. (NY:HHS) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $10.12 | 52 Week High | $14.48 | ||
| Open | $10.22 | 52 Week Low | $4.43 | ||
| Day High | $10.53 | P/E | 13.36 | ||
| Day Low | $10.10 | EPS | $0.76 | ||
| Volume | 153,696 | ||||
| More HHS Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| CVX | 2 | ALY | 2 |
| OSTK | 2 | PKD | 2 |
| AGP | 1 | BIP | 1 |
| DVA | 1 | HNT | 1 |
| MMP | 1 | PBI | 1 |
| SMTB | 1 | ACOR | 1 |
Entities who have mentioned HHS
- Dividend | View Related Stories »
- Matrix USA | View Related Stories »
- Deutsche Bank | View Related Stories »
- Trading Radar | View Related Stories »
- UBS | View Related Stories »
- BMO Capital | View Related Stories »
- Chicago PMI | View Related Stories »
- Chrysler LLC | View Related Stories »
- Bear Stearns | View Related Stories »
- Factory Orders | View Related Stories »
- Stock Buyback | View Related Stories »
- Life, Style and Real Estate | View Related Stories »
View All Major News StreetInsider.com Major News for HHS
- Harte-Hanks (HHS) POsts Q3 EPS of $0.22, In-Line with Street
- Harte-Hanks Inc. (HHS) Reports Q2 Results
- Harte-Hanks (HHS) Reports Mixed Q1 Results
View All ReportsStreetInsider.com Reports on HHS
- Harte-Hanks (HHS) Declares $0.075 Quarterly Dividend; 2.9% Yield
- Harte-Hanks (HHS) POsts Q3 EPS of $0.22, In-Line with Street
- Trading Radar for 11/03: UBS (UBS), Yamana Gold (AUY), Archer-Daniels (ADM), Royal Caribbean (RCL), Marathon (MRO) Report
- BMO Capital Downgrades Harte-Hanks (HHS) to Underperform
- Harte-Hanks (HHS) Declares $0.075 Qtr. Dividend, Yielding 2.18%
View All Press ReleasesCompany Press Releases on HHS
- Next Generation Web Content Management
- Data Driven Marketing: State of the Market
- Harte-Hanks and MedImmune Win Medical Marketing & Media Gold Award
- Offer Optimization Becomes a Reality: Aberdeen Group Reveals Combination of Technology and Customer Analytics as Keys to Improving Marketing Performance
- Harte-Hanks Board Declares Regular Quarterly Dividend
StreetInsider Reports on HHS by Category
View All BlogsBlogs on HHS
- BioMed News Bytes: Dyax, Human Genome Sciences, Aldagen
- 13 'Babies with Bathwater' Stocks for the Week
- Updated Dividend Growers List from the S&P 1500
- Harte-Hanks, Inc. Q2 2009 Earnings Call Transcript
- When Timing Meets Opportunity: Which Dividend Achievers Are at a 52 Week Low?
View All FilingsSEC Filings on HHS
- Form 4 HARTE CHRISTOPHER M For: Nov 04
- Form 10-Q HARTE HANKS INC For: Sep 30
- Form 8-K HARTE HANKS INC For: Nov 03
- Form 4 HARTE CHRISTOPHER M For: Oct 01
- Form 4 FARLEY WILLIAM F For: Oct 01
Comments on recent HHS articles
Comments on HHS
No comments are currently available.
on Nov 13, 2009
at 03:55 PM ANDREW OLIVER SATCHELL EXCELLENT
Article: Trading Radar for 11/03: UBS (UBS), Yamana Gold (AUY), Archer-Daniels (ADM), Royal Caribbean (RCL), Marathon (MRO) Report
on May 6, 2008
at 05:27 PM not to RUB it in !!! But I will gladly take over for whoever got FIRED for CROX (UGH !) Ready to make money, Marc Schaeffer, schafe1001@aol.com
Article: Matrix USA Rating Changes 1/08
on May 6, 2008
at 05:23 PM truly worse than a MONKEY?!?!? I own three funds (2 in a 401K), a half dozen stocks, and seem to be up roughly 22.1 % over the last 12-13 years. You guys REALLY get paid to put a SELL on CPD (do your KIDS do YOUR homework?) If you need a GOOD analyst, with a sound record and a BS from the University of Florida, you can reach me on Ft. Lauderdale Beach at 954-336-7746, Marc Schaeffer -- Hope to be of mutual benefit in making money !!!
Article: Matrix USA Rating Changes 1/08